Novo Nordisk shares fall on weight-loss drug trial
Novo Nordisk released the results from its late-stage trial of CagriSema on Monday. It showed that patients on the highest dose of the drug lost 15.7% of their weight.
Elon Musk polls X users on ending daylight saving time
Billionaire Elon Musk polled users of his social media platform X about remaining on daylight saving time permanently or staying on standard time throughout the year.
US healthcare innovation needs to be best in the world
Robert Kennedy Jr., in an interview with Fox’s Dr. Marc Siegel, is promising not only to Make America Healthy Again but to also improve the U.S. healthcare system and pharmaceutical innovations.
Musk says DOGE will quickly fix mistakes it makes in cutting programs
Elon Musk said that while the Department of Government Efficiency may make mistakes in its cost-cutting efforts, it will quickly look to fix them once identified.
Elizabeth Holmes' conviction was upheld: what are her next steps?
Theranos founder Elizabeth Holmes earlier this week received a denial for her appeal to overturn her conviction, and legal experts weighed in on what legal steps she can still take.
Eli Lilly cuts prices for Zepbound weight-loss drug again
Pharmaceutical giant Eli Lilly is once again expanding the supply of its weight-loss drug Zepbound and cutting the cost for patients that don't have insurance.
There is 'bloat in the federal government,' GOP lawmaker says
Rep. Keith Self, R-Texas, on the House readying for a reconciliation bill vote, Medicaid spending cuts, Veteran Affairs job cuts and progress reportedly being made to end the Russia-Ukraine war.
DOJ launches probe into UnitedHealth's Medicare billing practices: report
The Department of Justice has reportedly launched an investigation into UnitedHealth Group's Medicare billing practices, adding to the scrutiny the company is facing.
Gold is a 'good hedge' against market uncertainty – only in the short term: Expert
Pacer ETFs President Sean O'Hara argues gold is not a smart 'long-term' investment and reacts to a DOJ investigation into UnitedHealthcare.
US is 'not in a situation' to dole out DOGE dividend checks, GOP lawmaker says
Rep. Eric Burlison, R-Mo., weighs in on the idea for DOGE dividend checks, lawmaker concerns over Medicaid cuts, American energy reliability and his appointment to the House Declassification Task Force.
UnitedHealth stock crashes as DOJ investigates potential abuse, fraud
SlateStone Wealth chief market strategist Kenny Polcari discusses whether investors are overreacting to weak market news on 'Varney & Co.'
Trump says he will introduce 25% tariffs on autos, pharmaceuticals and chips
President Donald Trump is planning to impose 25% tariffs on imported automobiles as well as tariffs at a similar level on pharmaceutical imports and semiconductors.
GOP senator on DOGE exposing the government’s ‘lack of transparency’: ‘This is the swamp’
Sen. Roger Marshall, R-Kans., weighs in on the House GOP releasing its budget plan, trimming government spending, Trump's Cabinet picks being confirmed, DOGE's findings and Congress' reconciliation bill.
Walgreens permanently closing some stores in Southern California
Walgreens said five retail pharmacy stores in Southern California will close in late March, citing "increased regulatory and reimbursement pressures."
McDonald's takes massive sales hit from E. coli outbreak
McDonald's executives told analysts during an earnings call Monday that the company faced a financial blow from the deadly E. coli outbreak that occurred last year.
Trump, White House plan to cut federal health workers
‘The Big Money Show’ panel discusses the latest news on the White House planning to reduce the number of federal health workers.
Miss America dishes on why she supports MAHA, national unity
Miss America Abbie Stockard sheds light on her support for the 'MAHA' movement, how faith plays a role in her life and national unity.
Eli Lilly CEO reveals latest developments in Alzheimer's research
Eli Lilly & Company Chairman and CEO Dave Ricks sheds light on growth and success, the increase in weight loss drug popularity and research into Alzheimer's.
Bill Gates weighs in on new Trump administration, Elon Musk's role
Billionaire Microsoft co-founder and philanthropist Bill Gates discussed his recent meeting with President Trump and Elon Musk's role with the administration in a new interview.
Pfizer CEO: Cautiously optimistic on RFK, Jr. HHS secretary nomination
Pfizer CEO Albert Bourla unpacks the impact of the nomination on 'The Claman Countdown.'